Roche has selected Thomas Schinecker to serve as CEO of Roche Diagnostics, effective in August.
Mr. Schinecker, currently serving as Roche's head of centralized and point-of-care solutions, will succeed Michael Heurer, who is retiring at the end of July.
Mr. Heurer had been serving as interim CEO of the $13 billion diagnostics unit, which includes diabetes care and personalized cancer treatments.
Roche also announced that Peter Voser will leave Roche's board of directors by July.